Importantly, recent research revealed that inhibition of CERK increases VDAC-mediated mitochondrial membrane potential and generates cellular ROS in non-small cell lung cancer with KRAS mutations53. This evidence concerns the gene KRAS and non-small cell lung carcinoma.